EurekaMag
+ Translate
+ Most Popular
Cunninghamia lanceolata plantations in China
Mammalian lairs in paleo ecological studies and palynology
Studies on technological possibilities in utilization of anhydrous milk fat for production of recombined butter-like products
Should right-sided fibroelastomas be operated upon?
Large esophageal lipoma
Apoptosis in the mammalian thymus during normal histogenesis and under various in vitro and in vivo experimental conditions
Poissons characoides nouveaux ou non signales de l'Ilha do Bananal, Bresil
Desensitizing efficacy of Colgate Sensitive Maximum Strength and Fresh Mint Sensodyne dentifrices
Administration of fluid by subcutaneous infusion: revival of a forgotten method
Tundra mosquito control - an impossible dream?
Schizophrenia for primary care providers: how to contribute to the care of a vulnerable patient population
Geochemical pattern analysis; method of describing the Southeastern limestone regional aquifer system
Incidence of low birth weights in a hospital of Mexico City
Tabanidae
Graded management intensity of grassland systems for enhancing floristic diversity
Microbiology and biochemistry of cheese and fermented milk
The ember tetra: a new pygmy characid tetra from the Rio das Mortes, Brazil, Hyphessobrycon amandae sp. n. (Pisces, Characoidei)
Risk factors of contrast-induced nephropathy in patients after coronary artery intervention
Renovation of onsite domestic wastewater in a poorly drained soil
Observations of the propagation velocity and formation mechanism of burst fractures caused by gunshot
Systolic blood pressure in a population of infants in the first year of life: the Brompton study
Haematological studies in rats fed with metanil yellow
Studies on pasteurellosis. I. A new species of Pasteurella encountered in chronic fowl cholera
Dormancy breaking and germination of Acacia salicina Lindl. seeds
therapy of lupus nephritis. a two-year prospective study

Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer During Follow-Up and Prognosis


Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer During Follow-Up and Prognosis



Journal of the National Cancer Institute 111(4): 380-387



ISSN/ISBN: 0027-8874

PMID: 30312434

DOI: 10.1093/jnci/djy152

The prognostic relevance of circulating tumor cells (CTCs) at the time of primary diagnosis has been well established. However, little information is available regarding their prognostic relevance to follow-up care. The multicenter, open-label, phase III SUCCESS A trial compared two adjuvant chemotherapy regimens followed by 2 vs 5 years of zoledronate for early-stage, high-risk breast cancer patients. The presence of CTCs was assessed before and 2 years after chemotherapy using the FDA-approved CellSearch System. Overall survival (OS) and disease-free survival (DFS) were analyzed using univariate log-rank tests and multivariable Cox regressions. OS and DFS were measured starting from an assessment of CTCs 2 years after the completion of chemotherapy. All statistical tests were two-sided. The sample included 1087 patients who participated in the translational research program of the SUCCESS A trial and for whom sufficient translational data were available regarding CTC status at baseline and at the 2-year follow-up visit. Two years after chemotherapy, 198 (18.2%) patients were CTC-positive. The median follow-up after this timepoint was 37 months. Cox regressions that included CTC status at baseline revealed that CTC status 2 years after chemotherapy had statistically significant and independent prognostic relevance for OS (hazard ratio [HR] = 3.91, 95% confidence interval [CI] = 2.04 to 7.52, P < .001) and DFS (HR = 2.31, 95% CI = 1.50 to 3.55, P < .001). The presence of CTCs 2 years after chemotherapy was associated with decreased OS and DFS. Based on these results, active individualized surveillance strategies for breast cancer survivors based on biomarkers should be reconsidered.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 065887105

Download citation: RISBibTeXText

Related references

Does the Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer Patients Predict the Site of first Metastasis-Results from the Adjuvant SUCCESS a Trial. Cancers 14(16), 2022

Circulating tumor cells predict survival in early average-to-high risk breast cancer patients. Journal of the National Cancer Institute 106(5), 2014

Presence of circulating tumor cells (CTC) in metastatic breast cancer (MBC) predicts rapid progression and poor prognosis. Journal of Clinical Oncology 23(16_Suppl): 524-524, 2016

Cytokeratin 19-positive circulating tumor cells in early breast cancer prognosis. Future Oncology 6(2): 209-219, 2010

In Early Breast Cancer, the Ratios of Neutrophils, Platelets and Monocytes to Lymphocytes Significantly Correlate with the Presence of Subsets of Circulating Tumor Cells but not with Disseminated Tumor Cells. Cancers 14(14), 2022

Expression of stem cell and mesenchymal markers in circulating tumor cells is associated with poor prognosis of early breast cancer patients. Annals of Oncology: Official Journal of the European Society for Medical Oncology 28 Suppl. 7: Vii32, 2017

Presence of circulating tumor cells is associated with metabolic-related variables in postoperative patients with early-stage breast cancer. Chinese Journal of Cancer Research 30(3): 340-350, 2018

Detection of circulating tumor cells during follow-up of patients with early breast cancer: Clinical utility for monitoring of therapy efficacy. Scandinavian Journal of Clinical and Laboratory Investigation 74(2): 132-142, 2014

An exploratory study on the checkout rate of circulating tumor cells and the prediction of efficacy of neoadjuvant Therapy and prognosis in patients with HER-2-positive early breast cancer. Frontiers in Oncology 12: 966624, 2022

Detection of circulating tumor cells by RT-PCR of maspin in patients with high risk breast cancer undergoing high-dose chemotherapy. Acta Haematologica (Basel) 103(Suppl 1): 45, 2000

Prognosis of women with stage IV breast cancer depends on detection of circulating tumor cells rather than disseminated tumor cells. Annals of Oncology: Official Journal of the European Society for Medical Oncology 19(3): 496-500, 2008

Detection of circulating tumor cells and tumor stem cells in patients with breast cancer by using flow cytometry: a valuable tool for diagnosis and prognosis evaluation. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 33(2): 561-569, 2012

Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 26(8): 1208-1215, 2008

Circulating tumor cells before and during follow-up after breast cancer surgery. International Journal of Oncology 46(1): 407-413, 2015

Prediction of breast cancer metastasis risk using circulating tumor markers: A follow-up study. Bosnian Journal of Basic Medical Sciences 19(2): 172-179, 2019